Linio Biotech is an R&D company developing a category defining regenerative injectable for natural tissue augmentation, leveraging our proprietary Tience® technology.

Our goal is to create a paradigm shift in aesthetic medicine by replacing temporary fillers and invasive procedures with a safe, injectable, and biologically active product that regenerates soft tissue — naturally and sustainably.

Tience® technology is already in commercial use in the Nordics and supported by clinical research and real-world data. Now, we’re taking that foundation and applying it to a new indication with global potential.

Linio Biotech

Org chart

Teams

Offices